Scopus BioPharma (SCPS) News Today $0.0004 +0.00 (+33.33%) As of 08/29/2025 02:10 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock SCPS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Scopus Stock Price History - Investing.comJune 29, 2025 | investing.comScopus Biopharma Inc (SCPS) Stock Forums - Investing.comJune 29, 2025 | investing.comScopus Biopharma Inc Price / BookNovember 26, 2024 | investing.comScopus BioPharma (OTC:SCPS) Stock, Short Interest ReportOctober 8, 2024 | benzinga.comArgent Biopharma Stock (OTC:MGCLF), Quotes and News SummaryApril 17, 2024 | benzinga.comScopus Biopharma Inc (SCPS)February 14, 2024 | uk.investing.comArriVent BioPharma Inc AVBPFebruary 6, 2024 | morningstar.comMScopus BioPharma Inc. (SCPS)January 31, 2024 | finance.yahoo.com7+ Companies That Had Their IPO in 2020: Best and Worst PerformersJanuary 8, 2024 | msn.comScopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of CancerNovember 7, 2023 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of CancerNovember 2, 2023 | finance.yahoo.comKinnate Biopharma Inc Ordinary SharesJuly 15, 2023 | morningstar.comMScopus BioPharma Stock (OTC:SCPS), Insider Trading ActivityMay 16, 2023 | benzinga.comESG Industry Landscape Report: BiopharmaApril 19, 2023 | morningstar.comMYS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQMarch 18, 2023 | benzinga.comShort Volatility Alert: Scopus Biopharma IDecember 16, 2022 | benzinga.comWhy Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving PremarketDecember 15, 2022 | msn.comScopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of CancerNovember 10, 2022 | finance.yahoo.comScopus Biopharma Completes Recapitalization Designed To Enhance Shareholder ValueOctober 18, 2022 | finance.yahoo.comScopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of DirectorsMay 5, 2022 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies SummitMarch 22, 2022 | finance.yahoo.comScopus BioPharma Provides Update Following Annual Meeting of StockholdersJanuary 10, 2022 | finance.yahoo.comDR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORSJanuary 6, 2022 | finance.yahoo.comScopus Biopharma Inc Shares Approach 52-Week Low - Market MoverDecember 28, 2021 | nasdaq.comScopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the CompanyDecember 17, 2021 | finance.yahoo.comScopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy CardDecember 7, 2021 | finance.yahoo.comDr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With Upcoming Annual MeetingDecember 6, 2021 | finance.yahoo.comScopus BioPharma Announces $9.75 Million Private Placement Priced At-The-MarketNovember 22, 2021 | finance.yahoo.comScopus BioPharma Announces Adjournment of Annual Meeting of StockholdersOctober 8, 2021 | finance.yahoo.comScopus BioPharma to Present at the LD Micro Main EventOctober 5, 2021 | finance.yahoo.comScopus BioPharma Retaining Counsel to Investigate Unusual Market ActivityOctober 1, 2021 | finance.yahoo.comScopus BioPharma to Present at MicroCap Rodeo’s Fall Harvest Best Ideas ConferenceOctober 1, 2021 | finance.yahoo.comScopus BioPharma's Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics SocietySeptember 29, 2021 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet Therapeutics — Set to Release Scientific Data During the ...September 28, 2021 | apnews.comAScopus BioPharma to Adjourn 2021 Annual Meeting of StockholdersSeptember 28, 2021 | finance.yahoo.comScopus BioPharma’s Subsidiary Duet Therapeutics Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics SocietySeptember 28, 2021 | finance.yahoo.comScopus BioPharma to Present at the Benzinga Healthcare Small Cap ConferenceSeptember 23, 2021 | finance.yahoo.comChina National Intellectual Property Administration Grants New Patent Covering DUET-02, One of Three Key CpG-STAT3 Inhibitors Comprising the Duet PlatformSeptember 21, 2021 | finance.yahoo.comDr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual MeetingSeptember 20, 2021 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and Nagy Habib, Ch.M., F.R.C.S. to the Scientific Advisory BoardSeptember 14, 2021 | finance.yahoo.comScopus BioPharma to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 9, 2021 | finance.yahoo.comScopus BioPharma's Subsidiary -- Duet Therapeutics -- Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific AdvisorSeptember 9, 2021 | marketwatch.comScopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointment of Marcin ...September 8, 2021 | apnews.comAScopus BioPharma's Subsidiary - Duet Therapeutics - Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific AdvisorSeptember 7, 2021 | stockhouse.comScopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific AdvisorSeptember 7, 2021 | finance.yahoo.comScopus BioPharma's Subsidiary - Duet Therapeutics - to Present at the 14th Annual RNA Consortium MeetingSeptember 4, 2021 | stockhouse.comScopus BioPharma's Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA Consortium MeetingSeptember 3, 2021 | benzinga.comScopus BioPharma’s Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA ...September 3, 2021 | apnews.comAScopus BioPharma’s Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA Consortium MeetingSeptember 3, 2021 | finance.yahoo.comScopus BioPharma Launches Duet TherapeuticsSeptember 2, 2021 | finance.yahoo.com Get Scopus BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SCPS Media Mentions By Week SCPS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCPS News Sentiment▼0.001.05▲Average Medical News Sentiment SCPS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCPS Articles This Week▼00▲SCPS Articles Average Week Get the Latest News and Ratings for SCPS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Scopus BioPharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Syros Pharmaceuticals News Today Virpax Pharmaceuticals News Today Ainos News Today BriaCell Therapeutics News Today CytoMed Therapeutics News Today enGene News Today Fortress Biotech News Today Galapagos News Today GeoVax Labs News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCPS) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scopus BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scopus BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
